Findings from a recent study challenge a push to reclassify low grade prostate cancer, Biopsy Gleason Grade Group 1, as “benign.”
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
Some prostate cancer diagnoses more serious upon reexamination: Study
